These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27683458)

  • 1. miRNA in Prostate Cancer: New Prospects for Old Challenges.
    Mekhail SM; Yousef PG; Jackinsky SW; Pasic M; Yousef GM
    EJIFCC; 2014 Apr; 25(1):79-98. PubMed ID: 27683458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs as biomarkers in prostate cancer.
    Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
    Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminal plasma microRNAs improve diagnosis/prognosis of prostate cancer in men with moderately altered prostate-specific antigen.
    Barceló M; Castells M; Pérez-Riba M; Bassas L; Vigués F; Larriba S
    Am J Transl Res; 2020; 12(5):2041-2051. PubMed ID: 32509198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
    Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.
    Al-Kafaji G; Said HM; Alam MA; Al Naieb ZT
    Oncol Lett; 2018 Jul; 16(1):1357-1365. PubMed ID: 30061955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
    Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
    Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microRNAs in prostate cancer progression.
    Lo UG; Yang D; Hsieh JT
    Transl Androl Urol; 2013 Sep; 2(3):228-41. PubMed ID: 26813625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs.
    Bilal M; Javaid A; Amjad F; Youssif TA; Afzal S
    Transl Oncol; 2022 Dec; 26():101542. PubMed ID: 36148731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
    Oh-Hohenhorst SJ; Lange T
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer.
    Ghamlouche F; Yehya A; Zeid Y; Fakhereddine H; Fawaz J; Liu YN; Al-Sayegh M; Abou-Kheir W
    Transl Oncol; 2023 Feb; 28():101613. PubMed ID: 36608541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer.
    Shin S; Park YH; Jung SH; Jang SH; Kim MY; Lee JY; Chung YJ
    NPJ Genom Med; 2021 Jun; 6(1):45. PubMed ID: 34117264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.
    Moya L; Meijer J; Schubert S; Matin F; Batra J
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers.
    Jain G; Das P; Ranjan P; Neha ; Valderrama F; Cieza-Borrella C
    Front Genet; 2023; 14():1065757. PubMed ID: 36741322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.